BRPI0311511A8 - "preparações farmacêuticas líquidas, e sua aplicação". - Google Patents

"preparações farmacêuticas líquidas, e sua aplicação".

Info

Publication number
BRPI0311511A8
BRPI0311511A8 BRPI0311511A BRPI0311511A BRPI0311511A8 BR PI0311511 A8 BRPI0311511 A8 BR PI0311511A8 BR PI0311511 A BRPI0311511 A BR PI0311511A BR PI0311511 A BRPI0311511 A BR PI0311511A BR PI0311511 A8 BRPI0311511 A8 BR PI0311511A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparations
application
liquid pharmaceutical
thickener
oral application
Prior art date
Application number
BRPI0311511A
Other languages
English (en)
Inventor
Mertin Dirk
Edingloh Markus
Daube Gert
Original Assignee
Bayer Healthcare Ag
Bayer Animal Health Gmbh
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag, Bayer Animal Health Gmbh, Bayer Ip Gmbh filed Critical Bayer Healthcare Ag
Publication of BRPI0311511A publication Critical patent/BRPI0311511A/pt
Publication of BRPI0311511A8 publication Critical patent/BRPI0311511A8/pt
Publication of BRPI0311511B1 publication Critical patent/BRPI0311511B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PREPARAÇÕES FARMACÊUTICAS PARA A APLICAÇÃO ORAL CONTENDO RESINAS TROCADORAS DE ÍONS CARREGADAS COM SUBSTÂNCIA ATIVA BEM COMO FORMADORES DE GEL DE ESTRUTURA VISCOSA COMO ESPESSANTE". A presente invenção refere-se a preparações farmacêuticas para a aplicação oral, as quais contêm uma ou mais substâncias ativas, que são ligadas a um trocador de íons. Para o aperfeiçoamento da estabilidade física e da aceitância, especialmente nos animais, um formador de gel de estrutura viscosa está contido como espessante.
BRPI0311511-9A 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação". BRPI0311511B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10224086.8 2002-05-31
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (3)

Publication Number Publication Date
BRPI0311511A BRPI0311511A (pt) 2005-02-22
BRPI0311511A8 true BRPI0311511A8 (pt) 2017-07-11
BRPI0311511B1 BRPI0311511B1 (pt) 2018-07-10

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0311511-9A BRPI0311511B1 (pt) 2002-05-31 2003-05-19 "preparações farmacêuticas líquidas, e sua aplicação".
BR0311511-9A BR0311511A (pt) 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR0311511-9A BR0311511A (pt) 2002-05-31 2003-05-19 Preparações farmacêuticas para a aplicação oral contendo resinas trocadoras de ìons carregadas com substância ativa bem como formadores de gel de estrutura viscosa como espessante

Country Status (28)

Country Link
US (1) US8545829B2 (pt)
EP (1) EP1513500B1 (pt)
JP (2) JP5350574B2 (pt)
KR (3) KR101258373B1 (pt)
CN (1) CN1671361B (pt)
AR (2) AR039861A1 (pt)
AT (1) ATE421317T1 (pt)
AU (1) AU2003242545B2 (pt)
BR (2) BRPI0311511B1 (pt)
CA (1) CA2487648C (pt)
CR (1) CR7598A (pt)
DE (2) DE10224086A1 (pt)
DK (1) DK1513500T3 (pt)
ES (1) ES2319115T3 (pt)
HK (1) HK1083200A1 (pt)
HR (1) HRP20041219B1 (pt)
IL (2) IL165322A0 (pt)
MX (1) MXPA04011820A (pt)
MY (1) MY140953A (pt)
NO (1) NO333939B1 (pt)
PL (1) PL207269B1 (pt)
PT (1) PT1513500E (pt)
RU (1) RU2380091C2 (pt)
SI (1) SI1513500T1 (pt)
TW (1) TWI333422B (pt)
UA (1) UA84270C2 (pt)
WO (1) WO2003101422A2 (pt)
ZA (1) ZA200409616B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CA2661576A1 (en) * 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
CN102046202A (zh) * 2008-03-26 2011-05-04 塔罗制药北美有限公司 用于口服药剂的稳定脂质组合物
NZ602120A (en) 2010-03-12 2015-02-27 Monsanto Technology Llc Agrochemical gel compositions
HUE029400T2 (en) * 2010-05-19 2017-03-28 Astellas Pharma Inc Pharmaceutical composition containing Solifenacin
CA2852447A1 (en) 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
AU2019260015A1 (en) 2018-04-25 2020-12-17 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
EP0610341B1 (en) * 1991-10-28 1996-09-18 The Procter & Gamble Company Beverage thickener/emulsifier system
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
PT882049E (pt) * 1996-02-23 2003-04-30 Bayer Ag Acidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo-¬4.3.0|nonan-8-il)-6-fluoro-1,4-dihidro-4-oxo-quinolino-carboxilicos eventualmente substituidos e seus derivados
US5980882A (en) 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
ATE411047T1 (de) 1999-07-14 2008-10-15 Schering Plough Ltd Maskieren des geschmacks der oralen flüssigen chinolon-zubereitungen mit ionenaustauscherharzen
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
WO2003101422A2 (de) 2003-12-11
IL165322A (en) 2015-11-30
DK1513500T3 (da) 2009-05-11
DE10224086A1 (de) 2003-12-11
IL165322A0 (en) 2006-01-15
CR7598A (es) 2008-07-31
TWI333422B (en) 2010-11-21
AU2003242545A1 (en) 2003-12-19
HRP20041219A2 (en) 2006-02-28
NO333939B1 (no) 2013-10-28
DE50311123D1 (de) 2009-03-12
BRPI0311511B1 (pt) 2018-07-10
CN1671361B (zh) 2010-05-12
US8545829B2 (en) 2013-10-01
KR20120006092A (ko) 2012-01-17
EP1513500A2 (de) 2005-03-16
UA84270C2 (ru) 2008-10-10
MXPA04011820A (es) 2005-03-31
EP1513500B1 (de) 2009-01-21
JP2006503806A (ja) 2006-02-02
AR105798A2 (es) 2017-11-08
PT1513500E (pt) 2009-04-02
SI1513500T1 (sl) 2009-06-30
PL207269B1 (pl) 2010-11-30
AU2003242545B2 (en) 2010-02-18
ATE421317T1 (de) 2009-02-15
KR20050010015A (ko) 2005-01-26
HK1083200A1 (en) 2006-06-30
JP2011012087A (ja) 2011-01-20
US20060177414A1 (en) 2006-08-10
BR0311511A (pt) 2005-02-22
ES2319115T3 (es) 2009-05-04
HRP20041219B1 (hr) 2013-05-31
BRPI0311511A (pt) 2005-02-22
RU2004139022A (ru) 2005-07-10
ZA200409616B (en) 2006-05-31
RU2380091C2 (ru) 2010-01-27
AR039861A1 (es) 2005-03-02
JP5350574B2 (ja) 2013-11-27
TW200406230A (en) 2004-05-01
WO2003101422A3 (de) 2004-12-09
KR101258373B1 (ko) 2013-04-30
CA2487648C (en) 2012-03-13
NO20045700L (no) 2004-12-29
KR20120123607A (ko) 2012-11-08
MY140953A (en) 2010-02-12
PL373456A1 (en) 2005-08-22
CA2487648A1 (en) 2003-12-11
CN1671361A (zh) 2005-09-21

Similar Documents

Publication Publication Date Title
BRPI0311511A8 (pt) "preparações farmacêuticas líquidas, e sua aplicação".
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
BRPI0411982A (pt) glicano de aperfeiçoamento de terapia
BR0015048A (pt) Sal farmacêutico, medicamento, uso de pelo menos um sal de tramadol e formas de apresentação
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
BR0114927A (pt) Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR0207726A (pt) Sais farmacêuticos
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
ATE163540T1 (de) Retinoid enthaltende, wässrige, gelartige darreichungsform
DK0739197T3 (da) Konserverede oftalmiske lægemiddelpræparater, som indeholder polymere kvaternære ammoniumforbindelser
BR9803300A (pt) Formulação farmacêutica.
BRPI0411674A (pt) compostos, composição cosmética, uso cosmético de uma composição, uso de um composto, composição farmacêutica, e processo cosmético para o embelezamento da pele
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
DE69718734T2 (de) Bicyclisch-aromatische Verbindungen
FR2744452B1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
ES2187125T3 (es) Compuestos biciclicos-aromaticos y su utilizacion en medicina humana o veterinaria asi como en cosmetologia.
BRPI0611526A2 (pt) composição tópica contendo gelatina
DK0658553T3 (da) Hidtil ukendte polycykliske aromatiske forbindelser, farmaceutiske præparater og kosmetiske sammensætninger indeholdende di
BR9911833A (pt) Compostos diaril selenetos, composição farmacêutica, cosmética e sua utilização em medicina humana e veterinária, bem como em cosmetologia
BR0312318A (pt) Compostos, uso de um ou mais compostos, composição farmacêutica, composição cosmética e usos cosméticos
BR0211149A (pt) Preparados farmacêuticos contendo resinas trocadoras de ìons carregadas com substância ativa
BRPI0409790A (pt) 7-azaindóis e seu uso como terapêuticos